Shekar Patil

698 total citations
40 papers, 448 citations indexed

About

Shekar Patil is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Shekar Patil has authored 40 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 9 papers in Surgery. Recurrent topics in Shekar Patil's work include Lung Cancer Treatments and Mutations (10 papers), Oral Health Pathology and Treatment (6 papers) and Oral and Maxillofacial Pathology (5 papers). Shekar Patil is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Oral Health Pathology and Treatment (6 papers) and Oral and Maxillofacial Pathology (5 papers). Shekar Patil collaborates with scholars based in India, United Kingdom and Saudi Arabia. Shekar Patil's co-authors include B. S. Srinath, Gururaj Arakeri, Peter A. Brennan, Nalini Rao, Raghuram Nagarathna, Shivarama Varambally, K. S. Gopinath, M. Raghavendra Rao, Hongasandra Ramarao Nagendra and Matthias A.W. Merkx and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Shekar Patil

34 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shekar Patil India 11 174 130 84 61 55 40 448
Chad W. Wagoner United States 11 179 1.0× 55 0.4× 15 0.2× 16 0.3× 4 0.1× 28 316
Gloria J. Gross United States 12 332 1.9× 48 0.4× 7 0.1× 10 0.2× 11 0.2× 15 469
Ahmad Alzahrani Saudi Arabia 9 84 0.5× 51 0.4× 13 0.2× 2 0.0× 24 0.4× 42 281
Abelardo Meneses García Mexico 12 75 0.4× 96 0.7× 5 0.1× 2 0.0× 25 0.5× 39 379
Fabrizio Presicce Italy 15 47 0.3× 308 2.4× 3 0.0× 14 0.2× 68 1.2× 41 689
Michelle Goodman United States 8 145 0.8× 48 0.4× 5 0.1× 14 0.2× 20 0.4× 11 347
Davide Costa Italy 13 20 0.1× 42 0.3× 8 0.1× 6 0.1× 8 0.1× 58 386
Jennifer Bassett Midle United States 7 24 0.1× 12 0.1× 43 0.5× 4 0.1× 115 2.1× 10 382

Countries citing papers authored by Shekar Patil

Since Specialization
Citations

This map shows the geographic impact of Shekar Patil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shekar Patil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shekar Patil more than expected).

Fields of papers citing papers by Shekar Patil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shekar Patil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shekar Patil. The network helps show where Shekar Patil may publish in the future.

Co-authorship network of co-authors of Shekar Patil

This figure shows the co-authorship network connecting the top 25 collaborators of Shekar Patil. A scholar is included among the top collaborators of Shekar Patil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shekar Patil. Shekar Patil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prabhash, Kumar, Shekar Patil, Prabhat Singh Malik, et al.. (2025). Safety of nivolumab in treating Indian patients with non-small-cell lung carcinoma and renal cell carcinoma: A prospective multicenter study. Cancer Research Statistics and Treatment. 8(1). 12–20.
2.
Arakeri, Gururaj, et al.. (2023). Evaluation of fluoride levels in areca nut, tobacco, and commercial smokeless tobacco products: a pilot study. British Journal of Oral and Maxillofacial Surgery. 62(1). 76–82.
3.
Udupa, Kaviraja, R. M. Raghavendra, Amritanshu Ram, et al.. (2023). Effects of an 18-Week Integrated Yoga Program on Cardiac Autonomic Function in Breast Cancer Patients Undergoing Adjuvant Chemotherapy: A Randomized Controlled Trial. Integrative Cancer Therapies. 22. 1563483931–1563483931. 10 indexed citations
4.
5.
Arakeri, Gururaj, et al.. (2020). Long‐term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): A 3‐years follow‐up study. Journal of Oral Pathology and Medicine. 49(8). 803–808. 14 indexed citations
6.
Patil, Shekar, et al.. (2020). Does Yadgir population have copper-mediated intrinsic immunity to resist COVID-19 challenge?. Medical Hypotheses. 146. 110362–110362. 1 indexed citations
7.
Patil, Shekar, et al.. (2019). Management of leptomeningeal metastases in non-small cell lung cancer. Indian Journal of Cancer. 56(5). 1–1. 13 indexed citations
8.
Ramaswamy, Anant, Vikas Ostwal, Nikhil Pande, et al.. (2019). Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study. South Asian Journal of Cancer. 8(1). 22–26. 4 indexed citations
9.
Patil, Shankargouda, Gururaj Arakeri, Shekar Patil, et al.. (2019). Are electronic nicotine delivery systems (ENDs) helping cigarette smokers quit?—Current evidence. Journal of Oral Pathology and Medicine. 49(3). 181–189. 26 indexed citations
10.
Patil, Shankargouda, Gururaj Arakeri, Abdulwahab H. Alamir, et al.. (2019). Role of salivary transcriptomics as potential biomarkers in oral cancer: A systematic review. Journal of Oral Pathology and Medicine. 48(10). 871–879. 14 indexed citations
11.
Thungappa, Satheesh Chiradoni, et al.. (2017). Modified DOF regimen in advanced stomach cancer – A single centre experience from Bangalore.. Annals of Oncology. 28. iii44–iii44.
12.
Thungappa, Satheesh Chiradoni, et al.. (2017). P2.03b-064 Genomic Profiling in Non-Small Cell Lung Cancer: New Hope for Personalized Medicine. Journal of Thoracic Oncology. 12(1). S974–S975. 3 indexed citations
13.
Prabhu, Jyothi S., Aruna Korlimarla, Krisha Desai, et al.. (2017). Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease. Translational Oncology. 10(4). 699–706. 5 indexed citations
14.
Patil, Shekar, et al.. (2016). Targeted Therapy Management in NSCLC Patients Using Cytology: Experience from a Tertiary Care Cancer Center. Molecular Diagnosis & Therapy. 20(2). 119–123. 4 indexed citations
15.
Arakeri, Gururaj, et al.. (2016). Breath Alkane as an index of severity for oral submucous fibrosis: A new perspective?. Medical Hypotheses. 98. 18–20. 2 indexed citations
16.
Arakeri, Gururaj, Serryth Colbert, Shekar Patil, et al.. (2015). Salivary pooling: is it specific to particular regions in oral submucous fibrosis?. British Journal of Oral and Maxillofacial Surgery. 53(3). 275–278. 5 indexed citations
17.
Patil, Shekar, et al.. (2013). Epidemiological and clinical profile of patients with chronic myeloid leukemia at Health-Care Global, Bangalore Institute of Oncology. Indian Journal of Medical and Paediatric Oncology. 34(3). 211–212. 7 indexed citations
18.
Patil, Shekar, et al.. (2012). An uncommon case of an adult with del(5)(q) in acute lymphoblastic leukemia. Indian journal of human genetics. 18(3). 349–349. 1 indexed citations
19.
Scagliotti, Giorgio V., Keunchil Park, Shekar Patil, et al.. (2009). Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study. European Journal of Cancer. 45(13). 2298–2303. 32 indexed citations
20.
Rao, M. Raghavendra, Raghuram Nagarathna, Hongasandra Ramarao Nagendra, et al.. (2008). Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: A randomized controlled trial. Complementary Therapies in Medicine. 17(1). 1–8. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chad W. Wagoner Breakdown of academic impact, for papers by Gloria J. Gross Breakdown of academic impact, for papers by Ahmad Alzahrani Breakdown of academic impact, for papers by Abelardo Meneses García Breakdown of academic impact, for papers by Fabrizio Presicce Breakdown of academic impact, for papers by Michelle Goodman Breakdown of academic impact, for papers by Davide Costa Breakdown of academic impact, for papers by Jennifer Bassett Midle
Rankless by CCL
2026